Sun Pharma says, “We have taken all necessary steps in the best interest of patients and in accordance with regulatory requirements." | India News

Sun Pharma withdraws multiple eye drop products, asks distributors to stop sales and return stocks, citing patient safety and regulatory compliance.

"Withdrawal of Product - Depopred2ML, Brinolar (BKC FREE), Brinzotim Eye Drops 5ML BKC FREE, Lotepred-5ML, Lotepred 1% Eye Drops SML, Lotepred LS 0.2%E/D5ML, Lotepred T, Nepalact…